Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec

JAMA

Volumn 285, Issue 2, 2001, Pages 177-181

  De Wals, Philippe ^a   De Serres, Gaston ^b   Niyonsenga, Théophile ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; CANADA; CHILD; DRUG EFFICACY; FEMALE; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; PRIORITY JOURNAL; SERODIAGNOSIS; STATISTICAL ANALYSIS; TREATMENT FAILURE; VACCINATION;

EID: 0035835044     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.2.177     Document Type: Article

References (35)

1. Meningococcal infections in Quebec, 1991-1992
2. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992
3. Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada
4. Complications and sequelae of meningococcal disease in Quebec (Canada) 1990-1994
5. Impact of a mass immunization campaign against serogroup C meningococcus in the province of Quebec, Canada
6. Efficacy of meningococcal vaccine and barriers to vaccination
7. Vaccination programme for group C meningococcal infection is launched
8. Control of serogroup C meningococcal disease by mass vaccination in Catalogna (Spain)
9. Meningococcal vaccine and herd immunity
10. Induction of immunologic memory by conjugated vs plain meningococcal polysaccharide vaccine in toddlers
11. Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination
12. Canadian communicable disease surveillance system
13. Assessing vaccine efficacy in the field: Further observations
14. Evaluation of the completeness of reporting of invasive meningococcal disease
15. Thymus-independent and thymus-dependent responses to polysaccharide antigens
16. Human immunity to the meningococcus, I: The role of humoral antibodies
17. Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: Clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides
18. Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children
19. Immunogenicity of group A and group C meningococcal polysaccharides in human infants
20. Immune response of human infants to polysaccharide vaccines of group A and C Neisseria meningitidis
21. Induction of immunological memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine
22. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine
23. Avaliação do efeito protector de vacina polissacaridica antimenigococica da grupo C, em crianças de 6 a 36 meses
24. Meningococcal infections, II: Field trial of Group C meningococcal polyo saccharide vaccine in 1969-1970
25. Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines
26. Mucosal immune response to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents
27. Evaluation of group C meningococcal polysaccharide vaccine in marine recruits, San Diego, Calif
28. Prevention of meningococcal disease by group C polysaccharide vaccine
29. Human immunity to the meningococcus, V: The effect of immunization with meningococcal group C polysaccharide on the carrier state
30. Rapid serogroup switching in Neisseria rneningitidis
31. Serogroup B, electrophoretic type 15 Neisseria rneningitidis in Canada